What is a typical maintenance strategy after achieving remission in mild ulcerative colitis?

What is a typical maintenance strategy after achieving remission in mild ulcerative colitis?

• A. Immunomodulators or biologics are mandatory for all after remission
• B. No maintenance; relapse is expected
• C. Continued 5-ASA maintenance therapy
• D. Daily high-dose corticosteroids

Answer: (C)

In mild ulcerative colitis, the goal after remission is to keep the bowel inflamed under control and prevent relapse. The most appropriate maintenance strategy is to continue 5-aminosalicylic acid (5-ASA, such as mesalamine) as a ongoing, lower-dose background therapy. This approach helps sustain remission with a favorable safety profile, making it suitable for long-term use in mild disease. Immunomodulators or biologics aren’t required for every patient after remission; they’re typically reserved for those with more extensive or severe disease, steroid dependence, or failure to maintain remission on 5-ASA. Stopping maintenance and expecting relapse isn’t supported, since relapse can occur without ongoing therapy. Daily high-dose corticosteroids are not used for maintenance due to unacceptable long-term side effects and lack of sustained preventive benefit; they’re reserved for short-term induction of remission during flares, not ongoing maintenance.

In mild ulcerative colitis, the goal after remission is to keep the bowel inflamed under control and prevent relapse. The most appropriate maintenance strategy is to continue 5-aminosalicylic acid (5-ASA, such as mesalamine) as a ongoing, lower-dose background therapy. This approach helps sustain remission with a favorable safety profile, making it suitable for long-term use in mild disease. Immunomodulators or biologics aren’t required for every patient after remission; they’re typically reserved for those with more extensive or severe disease, steroid dependence, or failure to maintain remission on 5-ASA. Stopping maintenance and expecting relapse isn’t supported, since relapse can occur without ongoing therapy. Daily high-dose corticosteroids are not used for maintenance due to unacceptable long-term side effects and lack of sustained preventive benefit; they’re reserved for short-term induction of remission during flares, not ongoing maintenance.